Evidence map›Paper›PMID 30479395›Full record

ArticleThe Journal of antibiotics2019

Identification, molecular characterization, and structural analysis of the bla

Jhessyca Leal Melgarejo, Marlon Henrique Cardoso, Ingrid Batista Pinto, Célio Faria-Junior, Sónia Mendo, Carina Elisei de Oliveira, Octavio Luiz Franco

Abstract read
PubMed Publisher
In one paragraph

Article in The Journal of antibiotics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Characterization ofFrontiers in cellular and infection microbiology · 2025
    Article
  3. Facile Synthesis of 5-Bromo-Infection and drug resistance · 2024
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jhessyca Leal MelgarejoS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, MS, Brazil.
Marlon Henrique CardosoS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, MS, Brazil.ORCID http://orcid.org/0000-0001-6676-5362
Ingrid Batista PintoS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, MS, Brazil.
Célio Faria-JuniorNúcleo de Bacteriologia, Laboratório Central de Saúde Pública do Distrito Federal, Brasília, DF, Brazil.
Sónia MendoCESAM and Department of Biology, University of Aveiro, Campus de Santiago, Aveiro, Portugal.
Carina Elisei de OliveiraS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, MS, Brazil.
Octavio Luiz FrancoS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, MS, Brazil. ocfranco@gmail.com.
Universidade Católica Dom Bosco · BRUniversidade de Brasília · BRUniversity of Aveiro · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NDM-1 comprises a carbapenemase that was first detected in 2008 in New Delhi, India. Since then, NDM-1-producing Klebsiella pneumoniae strains have been reported in many countries and usually associated with intra and inter-hospital dissemination, along with travel-related epidemiological links. In South America, Brazil represents the largest reservoir of NMD-1-producing K. pneumoniae. Here, we focused on the detection and molecular/structural characterization of the bla

Indexed as

Anti-Bacterial Agentsbeta-Lactamasesbeta-Lactam ResistanceBrazilCarbapenemsCloning, MolecularComputational BiologyConserved SequenceGenotypeHospitalsHumansKlebsiella InfectionsKlebsiella pneumoniaeMicrobial Sensitivity TestsMolecular Docking SimulationMolecular TypingAnti-Bacterial Agentsbeta-lactamase NDM-1beta-LactamasesCarbapenems

Identifiers

PMID30479395
OpenAlexW2902878461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.